Today: 17 April 2026
Medical Properties Trust stock heads into holiday week after MPT sets dividend, earnings ahead
15 February 2026
1 min read

Medical Properties Trust stock heads into holiday week after MPT sets dividend, earnings ahead

New York, Feb 14, 2026, 19:39 EST — Market closed.

Shares of Medical Properties Trust fell 2.16% to close at $5.44 on Friday, a day after the hospital landlord revealed its next quarterly cash dividend.

U.S. markets are shut Monday for Washington’s Birthday, leaving investors with less time to reposition before the latest round of corporate updates hits. For a real estate investment trust — the kind that holds properties and hands back most of its earnings — that compressed schedule can make all the difference. Dividend payouts and funding costs often track closely with share prices.

The company has declared a dividend of $0.09 per share, payable April 9 to shareholders registered by March 12. The annual meeting is scheduled for May 28 in Birmingham, Alabama. The company reported 388 hospital facilities under its ownership as of September 30, with a combined total of about 39,000 licensed beds across nine countries.

MPT is set to drop its Q4 and full-year 2025 numbers before the bell on Thursday, Feb. 19. The company’s conference call kicks off at 11 a.m. Eastern. Investors will have until Feb. 26 to catch the replay.

Medical Properties Trust runs a hospital real estate game, rent payments from operators the main lifeblood—and that means rent flows and refi costs stay in sharp focus for shares. This day, traders are scanning for updates on incoming rent, where debt stands, and, crucially, hints about the dividend’s fate.

S&P 500 eked out a 0.05% gain Friday, pretty much flat. Healthpeak Properties surged 3.22%, while Boston Properties notched a 4.10% jump, MarketWatch data showed.

MPT slipped for a second straight day, deepening its slide with another drop after losing 2.46% on Thursday, according to price data. The stock traded in a narrow band, ranging from $5.42 to $5.64 Friday. Volume came in around 4.67 million.

Medical Properties Trust has rolled out a new NYSE ticker, shifting to “MPT” from “MPW” on Feb. 2 as part of its brand overhaul. Management says holders aren’t required to take any action in response. In a letter to shareholders, CEO Edward K. Aldag Jr struck an upbeat tone: “We are entering 2026 with a tremendous amount of confidence and conviction in our business model.” Medical Properties Trust

Even so, risk remains. Shares have shown they can tumble quickly when tenants run into trouble—witness Steward Health Care’s 2024 lawsuit against Medical Properties Trust. The bankrupt hospital operator alleged the landlord blocked hospital sales, underscoring just how abruptly operator issues can batter the stock.

The company’s quarterly dividend stands at 9 cents per share—so, 36 cents for the full year. With shares closing at $5.44 this Friday, the yield clocks in near 6.6%.

Trading picks up Tuesday, with eyes turning to the Feb. 19 results and that earnings call—potential catalysts for the next wave of stock action.

Stock Market Today

  • Nufarm ASX Share Rises on Strong 2026 EBITDA Guidance despite Lower Forecast
    April 16, 2026, 10:07 PM EDT. Nufarm (ASX: NUF) issued first-half fiscal 2026 underlying EBITDA guidance of $239-$244 million, marking a 17% increase from 2025 but below prior $265 million forecasts. Shares jumped 11% on the positive outlook. Gains stem from better crop protection margins, hybrid seed growth, omega-3 recovery, and bioenergy segments. Net debt fell 10% to $1.2 billion, with a net debt to EBITDA ratio of 2.4, improving by 20%. The company expects full-year net debt/EBITDA below 2.0. Despite challenges from previous omega-3 losses and competitive global markets, Nufarm's shares trade at a discount to its $3.50 fair value, reflecting a 16% EBITDA CAGR through 2030. Demand growth in sustainable agriculture and emerging markets underpins its expansion and profitability prospects.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
ASML share price in focus: what to watch Monday after chip-tool peer’s upbeat forecast
Previous Story

ASML share price in focus: what to watch Monday after chip-tool peer’s upbeat forecast

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 15.02.2026

Go toTop